BSC

Serial Number 98296340
Registration 7576878
700

Registration Progress

Application Filed
Dec 3, 2023
Under Examination
Approved for Publication
Sep 24, 2024
Published for Opposition
Sep 24, 2024
Registered
Nov 26, 2024

Trademark Image

BSC

Basic Information

Serial Number
98296340
Registration Number
7576878
Filing Date
December 3, 2023
Registration Date
November 26, 2024
Published for Opposition
September 24, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 26, 2024
Registration
Registered
Classes
035 042 045

Rights Holder

BIOMEDICAL STATISTICAL CONSULTING IP LLC

16
Address
2400 MARKET STREET, SUITE 200
PHILADELPHIA, PA 19103

Ownership History

Biomedical Statistical Consulting, Inc.

Original Applicant
03
Philadelphia, PA

Biomedical Statistical Consulting, Inc.

Owner at Publication
03
Philadelphia, PA

Biomedical Statistical Consulting, Inc.

Original Registrant
03
Philadelphia, PA

BIOMEDICAL STATISTICAL CONSULTING IP LLC

New Owner After Registration #1
16
PHILADELPHIA, PA

Legal Representation

Attorney
Melissa E. Scott

USPTO Deadlines

Next Deadline
1945 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-26)
Due Date
November 26, 2030
Grace Period Ends
May 26, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Mar 12, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 26, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 26, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 24, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 24, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 19, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 16, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 16, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 16, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 16, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 11, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 11, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 8, 2024 IUAA P USE AMENDMENT ACCEPTED Loading...
Jul 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 8, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 28, 2024 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Feb 28, 2024 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Feb 28, 2024 IUAF S USE AMENDMENT FILED Loading...
Feb 27, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 3, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries regarding clinical trials
First Use Anywhere: Sep 21, 1988
First Use in Commerce: Mar 3, 1999
Class 042
Consulting services for others in the field of guidance on the design of clinical trials; Consulting services for others in the field of expert review of proposed clinical trial design; data analysis of clinical trial results and clinical trial application submissions for others
First Use Anywhere: Sep 21, 1988
First Use in Commerce: Mar 3, 1999
Class 045
Representation of clients in biomedical and pharmaceutical regulatory proceedings
First Use Anywhere: Sep 21, 1988
First Use in Commerce: Mar 3, 1999

Additional Information

Pseudo Mark
BIOMEDICAL STATISTICAL CONSULTING

Classification

International Classes
035 042 045